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¤¤
¤¤
¤ Objectives:  We undertook this study to examine the
influence of demographics, peritoneal membrane trans-
port characteristics, nutrition indices, dialysis adequacy,
and comorbid diseases on patient survival on continu-
ous ambulatory peritoneal dialysis (CAPD), and to iden-
tify whether high peritoneal membrane transport is an
independent risk factor for mortality on CAPD.
¤¤
¤¤
¤ Design:  Our retrospective study was carried out in
CAPD patients in a large tertiary care teaching hospital.
¤¤
¤¤
¤ Methods:  Until December 2000, we followed 212 pa-
tients who started CAPD between 1994 and 1997 and who
underwent a peritoneal equilibration test (PET) within
3 months of CAPD initiation.
¤¤
¤¤
¤ Results:  By univariate analysis, comorbid diseases,
old age, high peritoneal transport, and serum albumin pre-
dicted patient mortality. Independent predictors of mor-
tality as determined by the Cox proportional hazard model
included diabetes mellitus, cardiovascular disease, serum
albumin, and old age. High peritoneal transport failed to
independently influence mortality in our CAPD patients.
KEY WORDS: Comorbid disease; peritoneal trans-
port; patient survival.
Age and comorbidity are the principal determi-nants of survival in continuous ambulatory peri-
toneal dialysis (CAPD) patients (1–5). Several stud-
ies incorporating multivariate analysis have indicated
that major comorbidity categories such as cardiovas-
cular disease (CVD) and diabetes mellitus (DM) have
a strong influence on mortality (3). Hypoalbuminemia,
malnutrition, and dialysis adequacy parameters are
also well-known risk factors for mortality in CAPD
patients (6). Recently, the role of peritoneal membrane
function—especially small-solute transport—has been
extensively studied in regard to patient outcome. Data
from both the CANUSA study (7) and the Stoke PD
study (8) reported that patients with high solute
transport have a greater probability of death as com-
pared with patients of other transport types. The pre-
dictive value of peritoneal solute transport in CAPD
patients is believed to depend on the type of
comorbidity present (9). Diabetes especially was re-
ported to be the most important risk factor for mor-
tality (10).
The purpose of the present study was to examine
the influence of peritoneal function on patient sur-
vival—alone, and in association with demographic
factors, comorbid diseases, and nutrition param-
eters—and to identify whether high peritoneal trans-
port is an independent risk factor for mortality in this
sample of CAPD patients.
PATIENTS AND METHODS
A total of 212 patients (115 men and 97 women)
who started CAPD at Yonsei Medical Center, Seoul,
Korea, from January 1994 to December 1997 were
included in the study. Patients were evaluated by PET
within 3 months of commencing CAPD. All subjects
were given a standard PET as described by
Twardowski et al (11). Using reference values for the
dialysate-to-plasma ratio of creatinine (D/PCr), pa-
tients were classified into one of the four peritoneal
transport types: high, high average, low average, and
low. The day before the PET, 24-hour urine (when di-
uresis was present) and drained dialysate were col-
lected to calculate the weekly standardized creatinine
clearance (SCCr) and Kt/V. The protein catabolic rate
(PCR) was calculated using the formula of Bergström
et al (12).
At the end of the study (December 2000), the
patient’s status was recorded as living, dead, or lost
to follow-up. Data for patients who had transferred
to hemodialysis or who had undergone renal trans-
plantation were censored.
Comparisons between the various peritoneal trans-
port types were performed by analysis of variance
(ANOVA), and comparisons between proportions were
done using the chi-square test. Survival analysis was
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done by the Kaplan–Meier method, and survival com-
parisons by factors and strata were done using the
log-rank test. Mortality risk was analyzed using the
Cox proportional hazard model, in which we included
all of the significant variables from the univariate
analysis.
RESULTS
CLINICAL CHARACTERISTICS
Among the 212 patients studied, the causes of end-
stage renal disease were chronic glomerulonephritis
(n = 54, 25.5%), hypertension (n = 49, 23.1%), DM
type 2 (n = 39, 18.4%), unknown (n = 53, 25.0%), and
other causes (n = 17, 8.0%). Table 1 shows the demo-
graphic and baseline clinical data according to peri-
toneal transport type. When patients were grouped
by peritoneal membrane transport characteristics,
9.9% were high transporters, 52.8% were high-aver-
age transporters, 29.7% were low-average transport-
ers, and 7.5% were low transporters. No statistical
differences were seen among the four transport groups
with regard to age at the start of PD, body weight,
body surface area, serum creatinine, weekly Kt/V and
SCCr, residual renal function (RRF), or nPCR. High
transporters had significantly more comorbid dis-
eases, such as diabetes and prior CVD. High trans-
porters were also significantly older as compared with
non high transporters. Drained dialysate volume and
initial serum albumin was lowest in high transport-
ers, and serum albumin level decreased as D/PCr
increased.
A further analysis was performed, comparing pa-
tient survival between patients with and without dia-
betes (Table 2). Diabetic patients were significantly
older; that group also had a higher proportion of pa-
tients with high transport characteristics and CVD.
Diabetic patients also had lower serum creatinine and
albumin levels as compared with non diabetic pa-
tients. The survival duration for diabetic patients was
significantly shorter than that for non diabetic pa-
tients. No differences were seen in weekly Kt/V and
SCCr, or RRF between diabetic and non diabetic
patients.
CLINICAL OUTCOME AND SURVIVAL
At December 2000, 109 patients were living on
CAPD, 46 had died, 29 had switched to hemodialysis,
and 28 had undergone kidney transplantation. The
46 patients who had died represented 38.1% (8/21) of
the high transport group, 19.6% (22/112) of the high-
average transport group, 22.2% (14/63) of the low-
average transport group, and 12.5% (2/16) of the low
transport group. When a comparison was made be-
tween living and deceased patients, the patients who
had died were significantly older, were more likely to
be men, and had more associated comorbid diseases
(Table 3). Among the 46 patients who had died, 15 had
no comorbid disease, 16 had diabetes, and 7 had CVD,
and 8 had both diabetes and CVD. Patients who died
had significantly lower initial serum albumin and
creatinine levels, but no significant differences in
weekly Kt/V and SCCr, nPCR, and RRF.
Figures 1 – 5 show the observed survival strati-
fied by peritoneal membrane transport, age, diabetes
status, CVD, and serum albumin computed by the
Kaplan–Meier method. Specifically, patients with high
transport, older age, DM, CVD, and low initial serum
PARK et al. CAPD OUTCOME NOT INFLUENCED BY HIGH TRANSPORT
TABLE 1
Baseline Characteristics of the Patients According to Peritoneal Transport Type
H HA LA L
Variable (n=21) (n=112) (n=63) (n=16) p Value
Age 55.8±9.8 49.6±12.3 43.8±14.0 50.6±12.7 NS
Men [n (%)] 12 (57) 69 (62) 29 (46) 5 (31) 0.06
Body weight (kg) 59.3±9.0 59.2±11.0 55.5±8.4 53.8±7.1 NS
BSA (m2) 1.63±0.16 1.63±0.18 1.57±0.15 1.54±0.12 NS
DM [n (%)] 9 (42.9) 22 (19.6) 7 (11.1) 1 (6.3) <0.05
CVD [n (%)] 6 (28.6) 10 (8.9) 6 (9.5) 1 (6.3) <0.05
Serum albumin (g/dL) 3.2±0.6 3.6±0.5 3.7±0.5 3.9±0.4 <0.01
Drained volume (mL) 2266±215 2397±196 2434±305 2495±307 NS
Weekly Kt/V 2.16±0.50 2.14±0.47 2.25±0.56 2.12±0.37 NS
Weekly SCCr (L/week/1.73 m
2) 81.5±25.1 79.5±29.8 76.7±28.3 74.3±25.1 NS
nPCR (g/day) 0.97±0.19 0.95±0.11 0.99±0.19 1.11±0.29 NS
RRF (mL/min) 1.3±1.4 1.8±2.1 1.7±1.9 2.8±3.8 NS
H = high transport; HA = high-average transport; LA = low-average transport; L = low transport; BSA = body surface area;
DM = diabetes mellitus; CVD = cardiovascular disease; Kt/V = dialysis dose, SCCr = standardized creatinine clearance;
nPCR = normalized protein catabolic rate; RRF = residual renal function.
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TABLE 3
Comparisons Between Survivors and Non Survivors
Survivors Non Survivors
Variable (n=166) (n=46) p Value
Age (years) 46.2±12.4 56.7±12.0 <0.01
Men [n (%)] 81 (48.8) 33 (71.7) <0.05
DM [n (%)] 15 (9.0) 24 (52.2) <0.01
CVD [n (%)] 8 (4.8) 15 (32.6) <0.01
Biochemical data
Blood urea nitrogen (mg/dL) 52.6±14.6 52.0±18.6 NS
Serum albumin (g/dL) 3.4±0.5 3.7±0.5 <0.01
Weekly Kt/V 2.18±0.54 2.19±0.48 NS
Weekly SCCr (L/week/1.73 m2) 79.5±35.3 78.9±30.4 NS
nPCR (g/kg/day) 0.98±0.20 0.95±0.21 NS
RRF (mL/min) 1.9±2.3 1.4±1.8 NS
DM = diabetes mellitus; CVD = cardiovascular disease; SCCr = standardized creatinine clearance; nPCR = normalized
protein catabolic rate; RRF = residual renal function.
TABLE 2
Comparisons Between Patients With and Without Diabetes Mellitus (DM)
With DM Without DM
Variable (n=39) (n=173) p Value
Age (years) 57.1±9.2 46.6±13.0 <0.05
Men [n (%)] 26 (66.7) 89 (51.4) NS
D/PCr 0.71±0.10 0.66±0.11 <0.05
High transport type [n (%)] 9 (23.1) 12 (6.9) <0.05
CVD [n (%)] 14 (35.9) 9 (5.2) <0.05
Survival duration (months) 38.0±21.4 51.1±16.3 <0.05
Biochemical data
Blood urea nitrogen (mg/dL) 51.5±17.3 52.6±15.0 NS
Serum albumin (g/dL) 3.2±0.6 3.7±0.5 <0.05
Weekly Kt/V 2.2±0.6 2.2±0.5 NS
Weekly SCCr (L/week/1.73 m2) 85.4±34.6 78.0±34.1 NS
nPCR (g/kg/day) 0.96±0.16 0.98±0.20 NS
RRF (mL/min) 1.8±2.1 1.8±2.2 NS
DM = diabetes mellitus; D/PCr = dialysate-to-plasma creatinine ratio; CVD = cardiovascular disease; Kt/V = dialysis dose;
SCCr = standardized creatinine clearance; nPCR = normalized protein catabolic rate; RRF = residual renal function.
Figure 1 — Survival curves according to peritoneal
transport type, by univariate analysis.
Figure 2 — Survival curves according to age, by univariate
analysis.
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albumin had a significantly shorter survival (Table 4).
Other variables such as weekly Kt/V and SCCr were
not significantly associated with survival in the
univariate analysis.
Peritoneal transport rate, DM, CVD, serum albu-
min, and age significantly predicted patient survival
in the univariate analysis. These variables were there-
fore included in the multivariate analysis. When sub-
jected to a stepwise multivariate analysis using the
Cox model, high transport status failed to predict
patient survival when the other covariates were in-
cluded (Table 5).
DISCUSSION
Many previous studies have demonstrated the pro-
found influence of comorbid disease on mortality in
CAPD patients (1–5). The present study provides fur-
ther evidence that age and comorbid diseases such
as DM and CVD are the important factors that pre-
dict survival in CAPD patients.
PARK et al. CAPD OUTCOME NOT INFLUENCED BY HIGH TRANSPORT
Figure 4 — Survival curves according to diabetes status,
by univariate analysis.
Figure 3 — Survival curves according to cardiovascular
disease, by univariate analysis.
Figure 5 — Survival curves according to serum albumin,
by univariate analysis.
TABLE 5
Independent Factors Prognostic of Mortality
(Multivariate Cox Proportional Hazard Model)
Relative
mortality
Factor risk p Value
Diabetes mellitus 3.918 <0.001
Cardiovascular disease 2.356 0.028
Serum albumin (<3.5 g/dL vs >3.5 g/dL) 2.222 0.015
Age 1.041 0.008
High peritoneal transport 0.555 0.210
TABLE 4
Prognostic Factors for Patient Survival
 (Univariate Analysis)
Surviving at
Variables Patients (n) 5 years (%)
Peritoneal transport typea
High 21 47.9
Non high 191 73.3
Age (years)a
<55 109 82.2
>55 103 49.4
Diabetes mellitusa
Without 173 81.4
With 39 26.7
Cardiovascular diseasea
Without 189 76.9
With 23 22.9
Serum albumin (g/dL)a
<3.5 73 53.0
>3.5 139 80.2
Weekly Kt/V
<2.1 93 62.5
>2.1 112 80.6
Weekly SCCr (L/week/1.73 m2)
<70 108 77.2
>70 114 71.1
a p < 0.05 by t-test.
SCCr = standardized creatinine clearance.
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High-average transport (52.8%) was the predomi-
nant peritoneal transport type in our study. The pro-
portions of patients with high transport (9.9%) and
low transport (7.5%) were lower than the proportions
reported for these transport types in previous stud-
ies in our population (13,14). The cause of this varia-
tion is not clear, but it may be related to the lesser
number of diabetic patients included in this study. It
is also possible that renal-failure patients who are
hypoalbuminemic and therefore more likely to be high
transporters are excluded from the dialysis program
because of selection criteria for long-term renal re-
placement therapy.
Peritoneal membrane function is widely believed
to have the potential to influence clinical outcome
(7,13). It is well established that the CAPD patients
with high peritoneal transport do not attain appropri-
ate ultrafiltration, and that they display the lowest
serum albumin levels (15–17). Both the CANUSA
study (7) and the Stoke PD study (8) have reported
the relationship between solute transport and patient
and technique survival in detail. The combined infor-
mation from those studies and from that of Wu et al
(18) appears to indicate that high peritoneal trans-
port predicts both patient survival and technique fail-
ure. However, Wang et al (16) found that a high
mortality rate with increased peritoneal permeability
was related to impaired fluid and small-solute removal
in high transporters. Blake suggested that the most
likely mechanism underlying the high mortality in
high transporters is the effect on cardiovascular sta-
tus, which is further impaired by fluid overload (19).
By univariate analysis, the high peritoneal trans-
port characteristic was an impressive mortality risk
factor in our study. The 5-year cumulative patient
survival of high transporters was significantly lower
as compared with non high transporters (47.9% vs
73.3%, p = 004). But when other covariates such as
DM, CVD, and older age were considered, the high
peritoneal transport characteristic lost statistical
power. This finding seems to be influenced by the high
peritoneal membrane permeability of diabetic pa-
tients and the high prevalence of DM in high trans-
porters in the present study. The ultrastructural
alterations such as thickening and reduplication of
capillary and mesothelial basal membranes observed
in diabetic angiopathy have been suggested to in-
crease peritoneal membrane permeability in diabetic
patients (20). Also, the increased mortality observed
in high transporters in our study could have been
influenced by the high prevalence of CVD in that
group. Heimbürger et al (21) reported that initial
D/PCr was significantly higher in patients with CVD.
The multivariate analysis of our data showed that
DM, CVD, older age, and low serum albumin were
important mortality risk factors. The most significant
PARK et al. CAPD OUTCOME NOT INFLUENCED BY HIGH TRANSPORT
risk factor among these was DM, a result that agrees
with previous studies reporting the prominent role of
this entity as a risk factor for mortality in CAPD pa-
tients (1–4,10). In the present study, diabetic patients
were significantly older and a higher proportion of
them had CVD, which is another well-known cause
of mortality in CAPD patients. Cardiovascular dis-
ease predicted mortality even after other covariates
such as DM and older age were considered. The com-
bined effect of older age and a higher proportion of
CVD probably accounted for the high mortality in
diabetic patients.
In contrast to previous studies by others (6,22,23),
dialysis adequacy parameters such as weekly Kt/V
and SCCr failed to predict patient survival in our study.
Davies et al (9) reported the predictive value of Kt/V
in association with comorbid diseases such as ischemic
heart disease and left ventricular dysfunction. The
lack of predictive power of the dialysis adequacy vari-
ables in our study may be due to the absence of sig-
nificant differences in weekly Kt/V or SCCr between
peritoneal transport types at the time of the PET.
Another factor that could have reduced the signifi-
cance of Kt/V is the high initial weekly Kt/V reported
in our patients. The weekly Kt/V values in the four
types of transporters in our study were all above 2.0;
in the study by Davies et al (9) these values were in
the range 1.61 – 2.04.
Serum albumin, although a time-dependent
marker, is generally accepted as an independent pre-
dictor of survival in CAPD patients (6,24). The present
study showed that the non survivors and the diabetic
patients had the lowest serum albumin levels. Cueto–
Manzano and Correa–Rotter analyzed the interaction
of serum albumin with DM and failed to find any pre-
dictive power for serum albumin in patient survival
(10). In the present study, serum albumin also dis-
played collinearity with DM, but a serum albumin
level below 3.5 g/dL significantly predicted patient
mortality even though comorbid diseases and age fac-
tors were included in the multivariate analysis. This
finding supports the observations of others that se-
rum albumin level correlates with clinical outcome
and is a significant predictor of mortality in CAPD
patients (6,22–24).
CONCLUSION
Our data suggest that DM is the most important
predictive factor for mortality in the present study
population. Even though high peritoneal transport
type predicted mortality in CAPD patients, its role
seemed to be influenced by other comorbid conditions.
Cardiovascular disease, hypoalbuminemia, and older
age were other important predictors of patient
survival.
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